REVE

SC 13G/A - Alpine Acquisition Corp. (0001853651) (Subject)

SC 13G/A - Alpine Acquisition Corp. (0001853651) (Subject)

SC 13G/A - Alpine Acquisition Corp. (0001853651) (Subject)

15-12G - Alpine Acquisition Corp. (0001853651) (Filer)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

Alpine Acquisition Corporation (the "Company") announced today that on April 6, 2023, it received a notice (the "Notice") from the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2022 (the "Filing"), the Company no longer complies with Nasdaq's rules for continued listing (the "Rules"). Under the Rules, the Company has 60 calendar days from the date of the Notice to submit a plan to regain compliance. If Nasdaq accepts the plan, it may grant an exception of up to 180 calendar days from the Filing's due date, or until September 27, 2023, for the Compa

FOUNTAIN HILLS, ARIZONA, April 10, 2023 (GLOBE NEWSWIRE) --  Alpine Acquisition Corporation (the "Company") announced today that on April 6, 2023, it received a notice (the "Notice") from the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2022 (the "Filing"), the Company no longer complies with Nasdaq's rules for continued listing (the "Rules"). Under the Rules, the Company has 60 calendar days from the date of the Notice to submit a plan to regain compliance. If Nasdaq accepts the plan, it may grant an exception of up to 180 calendar days from th

25-NSE - Alpine Acquisition Corp. (0001853651) (Subject)

Gainers SCYNEXIS, Inc. (NASDAQ:SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million. Palisade Bio, Inc. (NASDAQ:PALI) rose 49% to $2.51 after Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target. National CineMedia, Inc. (NASDAQ:NCMI) jumped 32.1% to $0.1510. National CineMedia is preparing for Chapter 11 filing, the Wall Street Journal reported last week. Boxed, Inc. (NYSE:BOXD) jumped 31.9% to $0.2120 after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankrupt

Gainers Boxed, Inc. (NYSE:BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives. Safe & Green Holdings Corp. (NASDAQ:SGBX) shares rose 30% to $1.05 in pre-market trading after the company reported Q4 results. Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 25.1% to $0.4443 in pre-market trading. Faraday Future Intelligent Electric announced the start of production of its flagship model, the FF91 Futurist Alliance. Mullen Automotive, Inc. (NASDAQ:MULN) rose 19.2% to $0.1240 in pre-market after jumping 11% on We

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

425 - Alpine Acquisition Corp. (0001853651) (Subject)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. First Citizens BancShares, Inc. (NASDAQ:FCNCA) shares surged 42.5% to $829.82 after First-Citizens Bank & Trust Company entered an agreement to purchase all deposits and loans of Silicon Valley Bank. Alpine Acquisition Corporation (NASDAQ:REVE) surged 32% to $14.17. Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares jumped 30% to $1.93 after gaining 8% on Friday. Jounce Therapeutics, Inc. (NASDAQ:JNCE) gained 23% to $1.86. Jounce Therapeutics entered into agreement to be acquired by Concent

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

425 - Alpine Acquisition Corp. (0001853651) (Subject)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

Expected to Reconvene March 28, 2023 at 12:00 p.m. Eastern Time FOUNTAIN HILLS, ARIZONA, March 14, 2023 (GLOBE NEWSWIRE) -- Alpine Acquisition Corporation ("Alpine" or the "Company") (NASDAQ:REVE) announced today that it intends to further adjourn its Special Meeting of Stockholders (the "Special Meeting") currently scheduled for March 16, 2023 to provide the Company additional time to complete the items necessary to consummate the Company's proposed business combination with Two Circus Inc. (as described further below) to be voted upon at the Special Meeting and to further engage with current and potential stockholders. The Company intends to adjourn the Special Meeting to March 28, 202

4 - Alpine Acquisition Corp. (0001853651) (Issuer)

425 - Alpine Acquisition Corp. (0001853651) (Subject)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

425 - Alpine Acquisition Corp. (0001853651) (Subject)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)

425 - Alpine Acquisition Corp. (0001853651) (Subject)

8-K - Alpine Acquisition Corp. (0001853651) (Filer)